The GSDME Gene Deafness Autosomal Dominant Type 5 Genetic Test is a specialized diagnostic procedure offered at DNA Labs UAE, designed to identify mutations in the GSDME gene that are associated with Autosomal Dominant Deafness Type 5 (DFNA5). This form of hearing loss is characterized by its genetic inheritance pattern, where a single copy of the mutated gene from an affected parent can lead to the condition in the offspring. The test plays a crucial role in the early detection and management of this type of hearing impairment, facilitating informed decisions regarding treatment options and preventive measures for at-risk family members. Priced at 4400 AED, this genetic test involves analyzing the individual's DNA to detect specific mutations in the GSDME gene, providing a comprehensive understanding of the genetic basis of their condition. By opting for this test at DNA Labs UAE, patients can expect accurate results, professional consultation, and guidance on the implications of their genetic profile in relation to Autosomal Dominant Deafness Type 5.
The POU4F3 gene plays a crucial role in the development and maintenance of hair cells in the inner ear, which are essential for hearing. Mutations in this gene can lead to autosomal dominant deafness type 52 (DFNA52), a form of progressive hearing loss that usually begins in adulthood. To diagnose this condition, individuals suspected of having DFNA52 can undergo genetic testing specifically targeting the POU4F3 gene.
DNA Labs UAE offers a specialized genetic test for identifying mutations in the POU4F3 gene associated with autosomal dominant deafness type 52. The test is comprehensive and designed to provide accurate results, aiding in the diagnosis and potential management of this hearing loss condition. The cost of the test is 4400 AED, reflecting the intricate processes and advanced technology involved in identifying the genetic mutation responsible for the condition. Undergoing this test at DNA Labs UAE ensures access to expert analysis and interpretation of the results, which can be crucial for affected individuals and their families in understanding the condition and exploring possible interventions or therapies.
The WFS1 gene, associated with Wolfram syndrome, plays a critical role in the inner ear's function, impacting hearing capabilities. Mutations in the WFS1 gene can lead to autosomal dominant nonsyndromic hearing loss, specifically classified as Deafness Autosomal Dominant Type 6 (DFNA6). This condition is characterized by progressive, sensorineural hearing loss, primarily affecting the high frequencies.
To diagnose this specific genetic cause of hearing loss, a genetic test targeting the WFS1 gene can be conducted. DNA Labs UAE offers this specialized testing service. The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for mutations in the WFS1 gene that are known to cause DFNA6.
The cost of the WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for individuals with a family history of hearing loss or those experiencing symptoms of hearing impairment, as it can provide a definitive diagnosis, inform about the progression of the condition, and guide management and treatment options. Additionally, the results can have implications for family planning for those affected or at risk.
The "DIABLO Gene Deafness Autosomal Dominant Type 64 Genetic Test" is a specialized genetic screening designed to identify mutations in the DIABLO gene, which are linked to Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) Type 64. This condition is characterized by varying degrees of hearing impairment that can be passed down through families. The test is a crucial tool for individuals with a family history of hearing loss, enabling early diagnosis and intervention strategies to manage the condition effectively.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing services, the test ensures accuracy and reliability in results. The cost of the test is set at 4400 AED, reflecting the intricate processes and sophisticated technology employed in detecting the specific genetic alterations responsible for this type of deafness. By opting for this test, individuals gain valuable insights into their genetic predisposition to hearing loss, empowering them with the knowledge to make informed decisions regarding their health and lifestyle.
The TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test is a specialized diagnostic tool designed to identify mutations in the TBC1D24 gene, which are linked to Autosomal Dominant Nonsyndromic Deafness 65 (DFNA65). This condition is characterized by progressive hearing loss that typically begins in childhood or early adulthood. The test aims to provide individuals and families with crucial genetic information that can aid in understanding their risk of developing this type of hearing impairment, as well as guide potential treatment and management strategies.
Conducted at DNA Labs UAE, a leading facility in genetic testing and personalized medicine, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed using advanced genomic technologies to detect any alterations or mutations in the TBC1D24 gene that are known to cause DFNA65.
The cost of the TBC1D24 Gene Deafness Autosomal Dominant Type 65 Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full testing procedure, analysis, and a comprehensive report that explains the results in detail. Patients are encouraged to discuss their results with a genetic counselor or a healthcare provider who can interpret the findings in the context of their personal and family medical history, and provide guidance on next steps.
This genetic test is particularly important for individuals with a family history of hearing loss, as it can provide valuable insights into the genetic basis of their condition and inform decisions about genetic counseling for family planning. It also contributes to the broader understanding of genetic deafness, paving the way for potential advancements in treatment and prevention strategies.
The "COCH Gene Deafness Autosomal Dominant Type 9 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the COCH gene, which are associated with a form of non-syndromic hearing loss known as Autosomal Dominant Deafness Type 9. This condition is characterized by progressive loss of hearing, primarily affecting the high frequencies, and in some cases, it may also involve vestibular dysfunction.
The test is conducted through a detailed analysis of the patient's DNA, extracted from a blood sample, to pinpoint any genetic alterations in the COCH gene that could lead to this specific type of hearing impairment. This genetic testing is crucial for early detection and management of the condition, allowing for a more targeted approach in treating the hearing loss and improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability, adhering to stringent quality standards. The cost of the test is set at 4400 AED, reflecting the comprehensive nature of the analysis and the advanced technology employed in identifying the genetic markers associated with Autosomal Dominant Deafness Type 9.
For individuals with a family history of hearing loss or those experiencing early signs of auditory impairment, this test offers a valuable diagnostic tool, facilitating early intervention and personalized care strategies to manage the condition effectively.
The "GJB3 Gene Deafness Autosomal Recessive Genetic Test" is a specialized diagnostic tool used to identify mutations in the GJB3 gene, which have been associated with non-syndromic hearing loss. This form of hearing impairment is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) to be affected. The GJB3 gene encodes a protein that is crucial for the function of cells in the inner ear, and mutations can disrupt this function, leading to hearing loss.
Conducted at DNA Labs UAE, this genetic test is designed to provide individuals and families with crucial information regarding the genetic basis of hearing loss, facilitating early intervention and management strategies. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the GJB3 gene.
The cost of the GJB3 Gene Deafness Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This price includes the full process of sample collection, genetic analysis, and a comprehensive report detailing the findings. The results from this test can help guide decisions about treatment options, including hearing aids, cochlear implants, and other supportive measures. Additionally, it provides valuable information for family planning and the assessment of risk in future offspring.
The CDH23 gene is associated with a form of deafness known as Autosomal Recessive Type 12. This condition is characterized by a mutation in the CDH23 gene, which plays a critical role in the structure and function of hair cells in the inner ear. These cells are essential for converting sound vibrations into electrical signals that the brain can interpret as sound. When mutations occur in the CDH23 gene, it can lead to significant hearing impairment or deafness from birth or early childhood.
To diagnose this specific type of genetic hearing loss, a genetic test targeting the CDH23 gene can be conducted. This test involves analyzing the DNA to identify mutations in the CDH23 gene that are known to cause Autosomal Recessive Type 12 deafness. The process typically requires a sample of blood or saliva from which DNA is extracted and then examined for the specific genetic changes.
In the UAE, DNA Labs offers this specialized genetic testing service. The cost of the CDH23 Gene Deafness Autosomal Recessive Type 12 Genetic Test at DNA Labs UAE is 4400 AED. This test is crucial for families with a history of hearing loss, as it can provide a definitive diagnosis of the condition. Moreover, understanding the genetic basis of the hearing loss can inform decisions about treatment and management, including the use of hearing aids, cochlear implants, and other interventions to support communication.
The STRC Gene Deafness Autosomal Recessive Type 16 Genetic Test is a specialized diagnostic procedure designed to identify mutations in the STRC gene, which are linked to autosomal recessive non-syndromic hearing loss (ARNSHL) of type 16. This condition is characterized by the absence of hearing from birth or early childhood without affecting other body systems. The STRC gene plays a critical role in the development and function of hair cells in the inner ear, which are essential for normal hearing.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for families with a history of hearing loss, providing them with valuable information regarding the genetic basis of their condition. By analyzing a small sample of blood or saliva, the test can confirm or rule out the presence of deleterious mutations in the STRC gene, thereby assisting in the diagnosis and guiding potential treatment or management options for affected individuals.
The cost of the STRC Gene Deafness Autosomal Recessive Type 16 Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers invaluable insights into the genetic underpinnings of hearing loss in affected families, allowing for informed decisions regarding care and support. Additionally, it can aid in the early detection and intervention for at-risk family members, potentially improving their quality of life.
The USH1C Gene Deafness Autosomal Recessive Type 18 Genetic Test is a specialized diagnostic procedure designed to detect mutations in the USH1C gene, which are linked to a form of deafness known as Autosomal Recessive Non-Syndromic Sensorineural Deafness Type 18. This condition is characterized by the congenital loss of hearing that occurs due to genetic mutations inherited from both parents. The test is crucial for early diagnosis, which can significantly aid in managing the condition through interventions such as hearing aids, cochlear implants, or other supportive therapies tailored to the patient's needs.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for specific mutations in the USH1C gene. The precision and reliability of the testing process at DNA Labs UAE ensure that individuals and families receive accurate genetic information, which is essential for understanding the risk of passing the condition to future generations and exploring possible treatments.
The cost of the USH1C Gene Deafness Autosomal Recessive Type 18 Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive process of genetic analysis and the provision of a detailed report, which includes interpretation of the results by qualified genetic counselors. This service is invaluable for affected individuals and their families, providing them with the necessary information to make informed decisions about their health and well-being.
